PTPN11 inhibitors
US11945815B2 · kind B2 · utility
0Cited by
6References
16Claims
0Family size
Inventors
Key dates
| Filing date | Jul 20, 2021 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Feb 10, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds which are useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.